KISSEI PHARMACEUTICAL CO., LTD. manufactures and sells a variety of prescription drugs.  The Company's main products are for cholesterol, high blood pressure, digestion, allergy, circulatory and respiratory diseases, and Parkinson's disease.

Notice Of Change To Scheduled Date To Commence Dividend Payments

Financial Briefing For The Second Quarter (Interim) Of The Fiscal Year Ended March 31, 2026 (Fiscal 2025)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Kissei Pharmaceutical (4547 JP)

Notice Of Change To Scheduled Date To Commence Dividend Payments

Financial Briefing For The Second Quarter (Interim) Of The Fiscal Year Ended March 31, 2026 (Fiscal 2025)

Notice Concerning Revisions To Financial Results Forecast

Consolidated Financial Results For The Six Months Ended September 30, 2025 [Japanese Gaap]

Supplementary Explanatory Materials On Financial Results For The Six Months Ended September 30, 2025

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)